Vazirani Asset Management LLC F Star Therapeutics, Inc. Transaction History

Vazirani Asset Management LLC

  • $47 Million
  • Q2 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$4.09 - $6.86 $511,250 - $857,500
125,000 New
125,000 $790,000

Others Institutions Holding FSTX

# of Institutions
3
Shares Held
44.7K
Call Options Held
0
Put Options Held
0
View Full List

About F-star Therapeutics, Inc.

FSTX Quotes by TradingView
  • Ticker FSTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 21,584,700
  • Description
  • F-star Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops tetravalent bispecific antibodies for cancer therapy. Its medicines are used in immuno-oncology treatments. The company's principal product candidate is FS118 and is being evaluated in a proof-of-concept Phase 2 trial in PD-1/PD-L1 acquired resistance head and neck c...
More about FSTX
Track This Portfolio

Track Vazirani Asset Management LLC Portfolio

Follow Vazirani Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vazirani Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vazirani Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email